What a Private Credit Continuation Vehicle Actually Is

A private credit continuation vehicle (PCV or CV) is a closed-end fund that acquires a portfolio of direct lending, mezzanine, or specialty financing positions from an aging sponsor fund that would otherwise need to liquidate them at a discount. Unlike equity continuation vehicles, which transfer operating company stakes, credit CVs move loan assets, revolving credit participations, and structured product exposures into a new vehicle with a fresh term (typically 3–5 years) and a new LP base. According to Kroll's secondary market research, continuation fund deal volume exceeded $100 billion in aggregate across equity and credit strategies by late 2025, with credit CVs representing a fast-growing subset.

Also worth reading: What are the most effective private credit redemption gate strategies for funds facing liquidity stress in 2026? · Tokenized private credit vs BDC: which is the better way to invest in private lending in 2026? · What are the definitive LPAC best practices for navigating continuation vehicle transactions in 2026?

The mechanics matter for valuation because the underlying collateral is contractual cash flow, not equity optionality. Each loan has a stated coupon, a maturity date, a covenant package, and a credit agreement that governs workout rights. The pricing question therefore reduces to: what is the present value of expected contractual and recovery cash flows, adjusted for credit risk, liquidity, and the structural protections embedded in the new vehicle?

Why Credit CVs Require Different Valuation Methods Than Equity CVs

Equity continuation funds are routinely priced using trading comparables, precedent transactions, and discounted cash flow models anchored on EBITDA multiples. Those tools are workable because equity has a residual claim on enterprise value. Credit CVs sit lower in the capital stack, which means recoveries are bounded by collateral coverage and contractual remedies rather than open-ended upside.

Morgan Lewis's 2025 analysis of sponsor finance noted that unitranche and second-lien direct loans in 2024–2026 have generally traded in a 96–101 range on cost, depending on coupon, sponsor relationship, and PIK toggles. That tight band is itself a valuation signal: when loans trade near par, mark-to-market adjustments are modest, and the CV valuation conversation shifts toward accrued interest, PIK capitalization, and the appropriate discount rate for illiquidity. By contrast, a 2025 cohort of more stressed credits — particularly in software, consumer discretionary, and certain healthcare subsectors — traded closer to 85–92, requiring more rigorous recovery analysis.

The Three Standard Valuation Approaches Used in Practice

Cost-based or mark-to-cost method. Many performing credit assets are carried at par plus accrued interest. In a CV, the lead lender's books reflect the most recent quarterly valuation, often informed by a third-party pricing service such as Russell, IDC, or S&P. The valuation report supporting the CV typically discloses the book figure, marks any non-accruing positions separately, and applies a small illiquidity discount of 50–200 basis points depending on the loan's credit rating and remaining duration. This is the dominant approach for broadly syndicated loans (BSL) and is referenced in Mayer Brown's Fund Finance guidance on valuation reports.

Yield-based or discounted cash flow method. For middle-market direct loans and unitranche exposures, sponsors and CV managers usually value using a discounted cash flow framework. The model projects contractual interest, principal amortization, and a terminal recovery assumption (typically 70–100% for senior secured, 30–60% for second lien, and 0–30% for mezzanine). Discount rates in 2025–2026 ranged from approximately SOFR + 450 bps for a BB-equivalent middle-market loan to SOFR + 900 bps for a single-B profile. Where SOFR fallback rates apply post-2026, secured overnight financing rates or term SOFR replacements are used.

Market comparables or precedent transaction method. Where comparable secondary trades exist — and they increasingly do, as reported in Kroll's secondary market evolution write-up — appraisers anchor on observed bid/ask spreads. Recent credit secondary transactions have cleared at discounts of 1–8% on cost for performing senior loans and 10–25% for PIK or watchlist names. These comparables are most useful when the loan pool is concentrated in a single sector or rating bucket.

How Valuation Reports and Fairness Opinions Fit In

Mayer Brown's 2025 guidance on valuation reports in fund finance makes a distinction that matters in practice: a valuation report quantifies what the assets are worth; a fairness opinion opines on whether the transaction terms (including price) are fair to the CV seller and continuing LPs relative to a market standard. Both are routinely required by LP advisory committees (LPACs) before approving a credit CV rollover.

The report typically includes a portfolio summary, methodology selection rationale, key assumptions (recovery rates, discount rates, prepayment assumptions), and a sensitivity table. It should also disclose any limitations on data — for example, the absence of audited financial statements for certain borrowers. ICLG's 2026 United Kingdom private equity chapter notes that under the UK AIFM framework, valuation must be performed by an independent valuer or by the AIFM itself under documented policies, and the methodology must be applied consistently across the fund.

Common Mistakes That Distort Credit CV Valuations

The most frequent error is using equity-style EBITDA multiples on portfolio companies and then adding a credit spread on top. Loan valuation should be anchored on the loan agreement, not the borrower's enterprise value. A second common mistake is ignoring PIK interest treatment: PIK that has compounded for two or three years can add 6–12% to the loan's accreted value relative to its original face, and omitting that inflation materially understates the CV's NAV.

A third issue is the treatment of unfunded commitments. Direct lending facilities often have revolver or delayed-draw tranches that the CV must either assume or reject. Treating unfunded exposure as zero-cost optionality is incorrect; if the CV assumes it, the commitment fee economics and likely draw schedule should be modeled. McKinsey's 2025 private credit review highlighted that revolving exposure in middle-market portfolios averages 8–15% of total fund commitments and that commitment valuation has become a more frequent LPAC question.

A fourth mistake is using a single discount rate for an entire pool when internal credit ratings vary materially. Splitting the pool by risk bucket and applying differentiated discount rates typically changes the headline NAV by 1–4%.

How Investors Should Review a Credit CV Valuation

Limited partners should request the full valuation report, not just a summary letter. They should compare the disclosed discount rate to the weighted average yield of the loans to confirm a reasonable spread for credit risk. They should test recovery assumptions by asking what NAV would result if recoveries were 10–15% lower. They should examine the illiquidity discount and ask whether it is consistent with recent secondary trades in comparable credits.

A practical step is to ask the CV manager for a 5% partial-sale scenario: at what price could 5% of the portfolio be sold in the secondary market within six months? If that implied price is materially below the reported NAV, the illiquidity discount is probably too thin. Kroll's research indicates that partial-portfolio secondary sales have become a useful triangulation tool precisely because they produce hard price discovery.

LPACs should also confirm that the valuation is dated within 90 days of the CV closing and that any loans placed on non-accrual after the valuation date are flagged. Post-valuation movements are a well-documented source of dispute in continuation fund closings.

Comparing the Three Valuation Methods

FeatureCost / Mark-to-CostDiscounted Cash FlowMarket Comparables
Best suited forPerforming BSL, short-duration paperMiddle-market direct loans, unitranchePortfolios with active secondary trading
Data requirementsQuarterly marks, pricing service feedsLoan agreement, borrower financialsRecent trade tickets, dealer runs
Sensitivity to assumptionsLowHigh (recovery, discount rate)Medium
Typical NAV variance vs cost-1% to +2%-8% to +4%-6% to +2%
Frequency of use in 2025–2026~60% of credit CVs~30%~10%
Acceptance by LPACsHigh for BSLHigh when auditedHigh when data is current
Most credit CVs in 2025–2026 used a blended approach: cost for the performing BSL sleeve, DCF for the middle-market sleeve, and comparables as a check on the aggregate NAV. InvestmentNews reporting on the SEC's probe into continuation vehicles noted that the agency has focused less on methodology choice and more on disclosure adequacy — whether the LP was told which method was used, who performed it, and what the key assumptions were.

When to Act and What the Cost Looks Like

A credit CV typically takes 4–7 months from concept to closing. Valuation work begins 60–90 days before launch and the fairness opinion 30–60 days before. Independent valuation reports cost roughly $50,000–$250,000 depending on portfolio size and complexity; fairness opinions add $75,000–$300,000. LPAC legal review costs another $50,000–$150,000. For a CV with $300–500 million in loan assets, total transaction expenses typically run 0.5–1.0% of NAV.

The LP vote window is usually 30–45 days after the formal disclosure of the CV terms. Investors who oppose a CV and do not elect to roll into the new vehicle typically receive a cash option at the rolled NAV (sometimes with a 5–10% opt-out discount). Under SEC scrutiny in 2025, several sponsors voluntarily extended the cash option window and improved disclosure of the valuation methodology, which has become a quiet market norm by mid-2026.

A Practical Decision Framework for Sponsors and LPs

Sponsors considering a credit CV should ask whether the loans are actually better held to maturity than sold. If the secondary market is offering 96–99 on cost for the performing sleeve, the cost of rolling (fees, illiquidity discount, and management drag) may exceed the secondary bid. If secondary bids are in the 88–94 range, a CV becomes more economically defensible. LPs should ask the same question from the other side: am I getting a better risk-adjusted outcome by rolling into a 4-year vehicle than by accepting a 6–10% discount to NAV today?

The honest answer in 2026 is that credit CVs are not a uniform good or bad. They are a tool, and like any tool, the result depends on the underlying portfolio quality, the governance around the rollover, and the transparency of the valuation. The market has matured to the point where the more sophisticated questions — around unfunded commitment treatment, PIK capitalization, and sensitivity disclosure — are the differentiators between a well-run CV and a problematic one.

What to Expect Through Late 2026

The SEC's continued focus on continuation vehicles has effectively raised the documentation floor. Independent valuations are now standard for credit CVs above $250 million. Fairness opinions are common above $500 million. The methodology disclosure in PPMs has become more granular, and LPAC challenges have produced more negotiation on the cash option price. These changes have raised transaction costs but reduced post-closing disputes.

McKinsey's 2025 review observed that private credit AUM globally crossed $2 trillion, with direct lending representing roughly half. As more vintage years mature, the pool of credit assets eligible for continuation vehicles will grow. The valuation methods described here — cost, DCF, and comparables — are unlikely to be displaced, but their relative weight will continue to shift toward DCF as middle-market direct loans become a larger share of the CV market.